U.S. Health Secretary Halts Enforcement on Six Unapproved Peptides
U. S. Health Secretary Robert F. Kennedy Jr. announced on October 28 in Washington, D.
C. , that the Department of Health and Human Services will cease enforcement against the sale of six compounded peptide drugs, despite FDA safety warnings. The announcement follows a temporary enforcement discretion the department granted earlier in the week, stating it would not pursue legal action against compounding pharmacies that produce the six peptides while a formal rule change is pending. Most FDA scientific staff had previously voiced opposition to the proposal, citing concerns about the compounds' safety.
Դերակատարներ
U.S. Department of Health and Human Services
Emily Hilliard
Dr. Peter Lurie
Shabbir Safdar
Medivant Healthcare
Տեղադրություններ
Washington, D.C., United States
